CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Celgene Corporation v. Cyclacel Pharmaceuticals Inc.

1:10-cv-00348

Overview

Case Number 1:10-cv-00348
Filing Date 2010-04-27
Status Terminated
Termination Date 2013-04-04
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:2201 Declaratory Judgment
Jury Demand Both

Parties

Plaintiff

Celgene Corporation NPE (Individual / Inventor)

Represented By

11 Attorneys Listed

John M. Michalik

Email: jmichalik@jonesday.com

Matthew A. Ferry

Email: mferry@jonesday.com

Xiaoyi Yao

Email: syao@jonesday.com

Timothy J. Heverin

Email: tjheverin@jonesday.com

Jose L. Patino

UNDELIVERABLE EMAIL 12/13/12

Anthony M. Insogna

Email: aminsogna@jonesday.com

Steven J. Corr

Email: sjcorr@jonesday.com

Philip A. Rovner

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Ryan J. Dwight

UNDELIVERABLE EMAIL 1/26/12

Nickou Oskoui

Email: noskoui@jonesday.com

Dale L. Rieger

Email: drieger@jonesday.com

Counter Claimant

Cyclacel Pharmaceuticals Inc. Operating Company

Represented By

7 Attorneys Listed

Elizabeth Rui He

ADDRESS EXPIRED / UNKNOWN

ADDRESS EXPIRED / UNKNOWN

Marvin S. Gittes

Email: msgittes@mintz.com

Frederick L. Cottrell , III

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Anne Shea Gaza

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6727

Rodney Square, 1000 North King Street

Timur Slonim

Email: teslonim@mintz.com

Jonathan M. Passner

UNDELIVERABLE EMAIL 1/26/12

John Bauer

Email: Jabauer@mintz.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6403555
Depsipeptide and congeners thereof for use as immunosuppressants
Filed: 2000-12-06
Issued: 2002-06-11
Expired (Term Ended)
Expires: 2020-12-06
US6548479
Therapeutic uses of depsipeptides and congeners thereof
Filed: 2002-04-02
Issued: 2003-04-15
Expired (Term Ended)
Expires: 2022-04-02
US6828302
Therapeutic uses of depsipeptides and congeners thereof
Filed: 2003-03-27
Issued: 2004-12-07
Expired (Term Ended)
Expires: 2023-03-27
US7041639
Depsipeptide and congeners thereof for use as immunosuppressants
Filed: 2004-10-08
Issued: 2006-05-09
Expired (Term Ended)
Expires: 2024-10-08

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

33

Dispositive

0

Granted

3

Denied

0

Pending / Review

30

Motions by Category

Procedural / Extension Motion 10 Motion to Strike / Sanctions 11 Claim Construction / Markman Filing 12

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
Joint APPENDIX re 124 Claim Construction Answering Brief, 123 Claim Construction Answering Brief Joint Appendix of Intrinsic Evidence by Celgene Corporation. (A...
Entry #127 • 2013-02-04 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 110 Claim Construction Opening Brief filed by Celgene Corporation. (Attachments: # 1 Exhibit 1)(Rovner, Philip) (Entered: ...
Entry #123 • 2013-01-31 Document →
Claim Construction / Markman Filing Pending / Under Review
CLAIM CONSTRUCTION ANSWERING BRIEF re 107 Claim Construction Opening Brief filed by Cyclacel Pharmaceuticals Inc.. (He, Elizabeth) (Entered: 01/31/2013)
Entry #124 • 2013-01-31 Document →
Claim Construction / Markman Filing Pending / Under Review
DECLARATION re 124 Claim Construction Answering Brief (Declaration of Niels Odum, M.D., D.M.Sc.) by Cyclacel Pharmaceuticals Inc.. (Attachments: # 1 Exhibit A-G...
Entry #125 • 2013-01-31 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to file the Joint Appendix of Intrinsic Evidence to February 4, 2013 - filed by Cyclacel Pharmaceuticals Inc.. (Gaza, Anne) (Entered:...
Entry #121 • 2013-01-30 Document →
Motion to Strike / Sanctions Granted
ORDER granting in part and denying in part 112 Motion to Strike. Signed by Chief Judge Gregory M. Sleet on 1/28/2013. (asw) (Entered: 01/28/2013)
Entry #119 • 2013-01-28 Document →

Docket Entries

(140 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Cyclacel Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 4292.) - filed by Celgene Corporation. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Acknowledgement of Consent Form, # 6 Civil Cover Sheet)(ksr) (Entered: 04/28/2010)

Entry #1 • 2010-04-27
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (ksr) (Entered: 04/28/2010)

Entry #2 • 2010-04-27
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,403,555 B1; US 6,548,479 B1; US 6,828,302 B1; US 7,041,639 B2; (ksr) (Entered: 04/28/2010)

Entry #3 • 2010-04-27
1

Disclosure Statement pursuant to Rule 7.1 filed by Celgene Corporation identifying Other Affiliate Janus Capital Management LLC for Celgene Corporation. (ksr) (Entered: 04/28/2010)

Entry #4 • 2010-04-27
1
Pleading / Complaint

SUMMONS Returned Executed by Celgene Corporation. Cyclacel Pharmaceuticals Inc. served on 4/27/2010, answer due 5/18/2010. (Rovner, Philip) (Entered: 04/28/2010)

Entry #5 • 2010-04-28
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc